跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 52 条关于
“SNIPRx”
全部
52
临床试验
21
药物
17
机构
4
资讯
10
去年
Repare Therapeutics Licenses Discovery Platforms to DCx Biotherapeutics in Strategic Refocus on Clinical Pipeline
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
去年
Repare Therapeutics to Present Phase 1 MYTHIC Trial Data of Lunresertib and Camonsertib Combination in Advanced Cancers
2年前
Camonsertib Shows Promise in ATM-Deficient Advanced Solid Tumors
去年
Repare Therapeutics Initiates Phase I Trial of RP-3467 for Advanced Solid Tumors
去年
Repare Therapeutics Reports 52% Reduction in Q2 Loss Amid Strategic Pivot to Licensing Model
去年
SNIPR Biome Doses First Patient with CRISPR-Armed Phage Therapy SNIPR001 for Drug-Resistant E. coli Prevention
6个月前
SNIPR's CRISPR-Armed Phage Therapy SNIPR001 Demonstrates Safety in First Human Trial
9个月前
Nigeria's NIPRD and FUTH Lafia Partner to Advance Local Vaccine and Drug Development
去年
Samsung Bioepis Partners with NIPRO to Commercialize Biosimilars in Japan, Including Ustekinumab Candidate